Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

NuvaRing Lawsuit Attorneys at The Oliver Law Group Comment on CNN Investigation into Alleged NuvaRing Side Effects
  • USA - English


News provided by

The Oliver Law Group

Jun 04, 2014, 23:30 ET

Share this article

Share toX

Share this article

Share toX

Contact the Oliver Law Group P.C. for your free NuvaRing lawsuits case review by calling toll free 800-939-7878 today or visiting www.legalactionnow.com.
Contact the Oliver Law Group P.C. for your free NuvaRing lawsuits case review by calling toll free 800-939-7878 today or visiting www.legalactionnow.com.

Contact the Oliver Law Group P.C. for your free NuvaRing lawsuits case review by calling toll free 800-939-7878 today or visiting www.legalactionnow.com.

Post this

Chicago, IL (PRWEB) June 04, 2014 -- The NuvaRing lawsuit attorneys at The Oliver Law Group note that CNN will air a series of investigative reports detailing the serious, and potentially deadly side effects, allegedly suffered by young women who have used the NuvaRing vaginal ring birth control device. According to an article which appeared in the Durango Herald on June 2, 2014, the series of broadcasts will air during Anderson360, and will feature the family of one young woman who allegedly died after suffering a blood clot brought on by NuvaRing. The young woman’s family is now pursuing a NuvaRing lawsuit against Merck & Co., the manufacturer of the contraceptive ring.
[cnn.com/video/data/2.0/video/us/2014/06/01/nr-dnt-nuvaring-investigation.cnn.html , CNN June 1, 2014]
[durangoherald.com/article/20140602/NEWS01/140609932/-1/taxonomy/Parents-of-young-woman-to-appear-on-CNN-, Durango Herald, June 2, 2014]

Rick and Karen Langhart, the parents of Emily Langhart, have made it a mission to inform the public about the risks associated with NuvaRing. In addition to CNN, their daughter’s story has appeared in Vanity Fair Magazine and other media outlets. The have also created a nonprofit organization, Informed Choice for Amerika (the “k” is in honor of Erika), that is working to get the word out, according to the Durango Herald.
NuvaRing is a monthly contraceptive device that is marketed by Merck & Co. as being more convenient, but just as effective and safe as oral birth control bills. According to a report that aired last month on Arizona’s 3TV, the U.S. Food & Drug Administration (FDA) has received more than 1,000 reports of NuvaRing blood clots, some of which proved fatal. Yet the agency has not acted to mandate more prominent safety warnings for the product.
[azfamily.com/news/Monday--9-pm-on-3TV-Controversial-product-257730441.html, 3TV, May 6, 2014]

A number of studies have also linked NuvaRing to an increased risk of blood clots, heart attacks, strokes and death. These studies include research released by the FDA in 2011 which found a 56% increased NuvaRing blood clot risk, including a higher danger of deep vein thrombosis and pulmonary embolism, compared to oral contraceptives. In the summer of 2012, research published in both The New England Journal of Medicine and the British Medical Journal indicated that NuvaRing side effects included a higher risk of potentially deadly blood clots, as well as heart attacks and strokes.
[fda.gov/Drugs/DrugSafety/ucm277346.htm; FDA, October 27, 2011]
[nejm.org/doi/full/10.1056/NEJMoa1111840; NEJM, June 2012]
[bmj.com/content/344/bmj.e2990/rr/585117, British Medical Journal, May 2012]

Court documents indicate that more than 1,700 NuvaRing lawsuits are now pending in a federal litigation underway in U.S. District Court, Eastern District of Missouri, all of which allege use of the vaginal ring caused heart attacks, strokes, blood clots and cardiac death. (In Re NuvaRing Products Litigation, 08-md-01964) Just over 215 similar cases have been filed in New Jersey Bergen County Superior Court. Earlier this year, Merck agreed to pay $100 million to resolve the NuvaRing lawsuits pending in these proceedings. If finalized, court records indicate that the NuvaRing settlement will provide an average of $58,000 to each plaintiff. However, women who claim to have suffered the most severe injuries, as well as the families of women who allegedly died due to NuvaRing injuries, will receive higher payments.

The Oliver Law Group offers free NuvaRing lawsuit evaluations to alleged victims of NuvaRing side effects. If you or someone you love suffered a blood clot, pulmonary embolism, deep vein thrombosis, heart attack, stroke or sudden death while using NuvaRing, please visit http://www.legalactionnow.com, or call toll-FREE 1-(800) 939-7878 to learn more about your options for legal recourse.

Contact Oliver Law Group P.C. To Learn More About Filing A NuvaRing Lawsuit
Oliver Law Group P.C. is a different kind of law firm. One that focuses on the needs of the injured first. A compassionate law firm dedicated to fighting for the rights of victims and their families, and doing everything necessary to ensure those rights.

The experience of a large firm. The 1-on-1 dedication of a small firm. A reputation built on trust.
Experience. Dedication. Trust. Oliver Law Group P.C.

If you would like to learn more about filing a NuvaRing lawsuit, turn to the law firm with the Experience, Dedication, and Trust you deserve. Contact the Oliver Law Group P.C. for your free NuvaRing lawsuits case review by calling toll free 800-939-7878 today or visiting http://www.legalactionnow.com.

Contact:
The Oliver Law Group
950 W University Drive
Suite #200,
Rochester, MI 48307
(800) 939-7878

Alyson Oliver, The Oliver Law Group, http://www.legalactionnow.com, +1 800-939-7878, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.